Snehal brings a confluence of early discovery, innovation and scientific expertise to her current role of regulatory scientist and North America regulatory liaison supporting cell and gene therapies and microbiome.
With a keen interest in influencing regulatory policies in fields of regenerative medicine and advanced therapies, she staffs the regulatory committee and gene therapy section of the Alliance for Regenerative Medicine, and is an active member of the American Society of Gene & Cell Therapy and New York Academy of Sciences.
With a penchant for exploring the unexplored, she has led biology programs at both Pfizer’s Centers for Therapeutic Innovation and J&J’s Janssen Incubator.
Snehal holds an AB-MA in Biology from Bryn Mawr College and a Ph.D. in Molecular Genetics and Genomics from Washington University in St. Louis. As an invited main stage speaker at TedxJNJ and panelist for the New York Academy of Sciences Global STEM Alliance Summit, she is a practiced public speaker.